NCT06648070 "Effects of Neuromuscular Reeducation Versus Post Facilitation Stretch Technique for Upper Cross Syndrome Among IT Professionals
| NCT ID | NCT06648070 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Foundation University Islamabad |
| Condition | Upper Cross Syndrome |
| Study Type | INTERVENTIONAL |
| Enrollment | 44 participants |
| Start Date | 2024-07-15 |
| Primary Completion | 2025-07-15 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 44 participants in total. It began in 2024-07-15 with a primary completion date of 2025-07-15.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study is a randomised control trial and the purpose of this study is to determine the "Effects of Neuromuscular Reeducation Versus Post Facilitation Stretch Technique for Upper Cross Syndrome among IT professionals .
Eligibility Criteria
Inclusion Criteria: * IT profressionals * 20 - 40 years * Both genders * Diagnosed UCS * Pain from 2 months * Minimum 4 - 6 hiurs working Exclusion criteria: * History of cervical spine * Fracture * Trauma to neck
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06648070 clinical trial?
This trial is open to participants of all sexes, aged 20 Years or older, up to 40 Years, studying Upper Cross Syndrome. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06648070 currently recruiting?
Yes, NCT06648070 is actively recruiting participants. Contact the research team at hinaayub881@gmail.com for enrollment information.
Where is the NCT06648070 trial being conducted?
This trial is being conducted at Rawalpindi, Pakistan.
Who is sponsoring the NCT06648070 clinical trial?
NCT06648070 is sponsored by Foundation University Islamabad. The trial plans to enroll 44 participants.